ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial
Introduction Both rituximab (RTX) and cyclophosphamide (CYC) are effectively used in combination with steroids as remission induction therapy for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Several studies have shown that the effect on achieving (clinical) r...
Main Authors: | Cees van Kooten, Y K Onno Teng, Willem Jan Bos, Obbo W Bredewold, Argho Ray, Jacqueline T Jonker, Hilde H F Remmelts, Ebru Dirikgil, Jolijn R van Leeuwen, Darius Soonawala, Bastiaan van Dam, Joris Rotmans, Ton Rabelink, Laura S van Dam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/9/e061339.full |
Similar Items
-
LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients
by: Obbo W Bredewold, et al.
Published: (2024-03-01) -
Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases
by: Laura S. van Dam, et al.
Published: (2019-02-01) -
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
by: Mieke van Schaik, et al.
Published: (2022-11-01) -
GNSS Transpolar Earth Reflectometry exploriNg System (G-TERN): Mission Concept
by: Estel Cardellach, et al.
Published: (2018-01-01) -
Valors adverbials associats a la conjunció «que»: un estudi històric
by: Montserrat Batllori, et al.
Published: (2014-10-01)